Diagnostic Imaging Market By Product Type (X-ray Imaging Systems, Computed Tomography Systems, Magnetic Resonance Imaging Systems, Ultrasound Systems, Nuclear Imaging Systems, Mammography Systems); By Portability (Fixed/Standalone Systems, Portable/Mobile Systems); By Application (Cardiology, Oncology, Neurology, Orthopedics, Obstetrics and Gynecology, Gastroenterology, Others); By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Specialty Clinics, Others); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Diagnostic Imaging Market: Rising Scan Volumes, AI-Enabled Efficiency, and Multi-Regional Growth  – (Updated On: 19-Aug-2026)

The Global Diagnostic Imaging Market was valued at USD 45.60 billion in 2025 and is projected to reach USD 65.46 billion by 2032, expanding at a CAGR of 5.3% during 2026–2032.

 

Diagnostic imaging refers to the use of medical technologies to produce images of the inside of the body so doctors can identify diseases, monitor health conditions, plan treatments, and guide medical procedures. It includes methods such as X-ray, CT scans, MRI, ultrasound, mammography, fluoroscopy, PET/CT, and SPECT. According to the FDA, each imaging technique provides different types of information, so the choice of method depends on the specific medical need, and no single technique can replace all others.

 

In parallel, several imaging-related technologies used within diagnostic workflows have received FDA clearance under different regulatory pathways, including 510(k) clearances for AI-enabled image reconstruction, computer-aided detection, and workflow optimization software. These FDA-cleared mechanisms of action (MoA) are primarily non-pharmacological and are based on algorithmic image enhancement, automated lesion detection, dose optimization, and reconstruction acceleration rather than traditional drug-based mechanisms.

 

In the United States, diagnostic imaging utilization is extremely high, with more than 100 million imaging examinations performed annually across hospital, outpatient, and emergency care settings, driven by CT, MRI, X-ray, ultrasound, and nuclear medicine procedures across Medicare, Medicaid, and private payer populations. On a global scale, industry and health-system estimates indicate that more than 3.6 billion diagnostic imaging examinations are conducted each year, reflecting the widespread use of imaging as a first-line diagnostic tool across both developed and emerging healthcare systems.

 

Which Imaging Modalities Are Creating the Strongest Commercial Opportunities?

X-ray remains the largest modality by examination volume in many general diagnostic settings. NHS England recorded more than 23.4 million X-ray examinations during the 12 months ending March 2026, substantially ahead of other individual modalities. For suppliers, however, growth opportunities are concentrated less in basic image acquisition and more in digital detector replacement, mobile radiography, automated positioning, workflow integration, image-quality optimization, and replacement of aging systems.

Ultrasound accounted for approximately 11.84 million examinations in England over the same period. Its relatively flexible deployment model makes it particularly suitable for outpatient clinics, community diagnostic centres, women's health, cardiovascular care, emergency settings, and point-of-care expansion. The planned addition of ultrasound capacity at Eltham illustrates how health systems can add examination capacity without constructing the infrastructure required for MRI or CT.

CT is one of the most important imaging segments due to its high use in emergency care, oncology, cardiovascular disease, trauma, and other critical conditions. In England, nearly 8.8 million CT scans were performed in the 12 months to March 2026, showing strong and sustained demand.

Growth is also being driven by large public investments in emerging markets. In Indonesia, the Ministry of Health’s IHSS/SIHREN program includes procurement of 320 CT systems, with contracts signed in 2025 and phased deliveries planned. GE HealthCare is also supplying more than 300 advanced CT scanners in the country, along with earlier MRI system contracts for public hospitals.

MRI has a smaller procedure base than CT but remains commercially attractive because of its high equipment value, infrastructure requirements, service contracts, software upgrades, and continued demand for additional capacity. England conducted more than 5.04 million MRI examinations during the year ending March 2026, while Canadian data continue to show MRI waiting-time pressure. This supports investment not only in additional magnets but also in faster acquisition, reconstruction technologies, remote operation, workflow automation, and software that can increase examinations per scanner.

PET/CT and other molecular-imaging modalities have much lower examination volumes but are becoming strategically more important as oncology and advanced diagnostic pathways expand. Canada's inventory identified 60 PET/CT units across nine provinces and approximately 156,320 publicly funded PET/CT examinations in fiscal 2022–23, with oncology accounting for the majority of demand. Their commercial economics depend heavily on both scanner capacity and radiopharmaceutical reimbursement, making payment policy particularly important to this segment.

 

How Is the Diagnostic Imaging Market Structured?

Largest Diagnostic Imaging Market Share by Product Type

X-ray Imaging Systems led the product-type segment with a 24.5% market share, equivalent to approximately USD 11.17 billion in 2025, and are projected to expand at a CAGR of 4.7%. Their large revenue position reflects the broad installed base across hospitals, diagnostic centers, emergency departments, outpatient facilities, and general radiology settings.

Computed Tomography (CT) Systems accounted for 20.5% of the market, representing approximately USD 9.35 billion in 2025, and are expected to grow at a CAGR of 5.8%. High utilization in emergency imaging, oncology, cardiovascular assessment, trauma, and public-sector capacity programs supports continued investment in both new CT installations and replacement systems.

Magnetic Resonance Imaging (MRI) Systems represented 18.5% of the market, valued at approximately USD 8.44 billion in 2025, and are projected to record the fastest product-type CAGR of 6.1%. Expansion is supported by demand for additional scan capacity, higher-field systems, faster acquisition, advanced reconstruction, remote operation, and software-led workflow improvements.

Ultrasound Systems held a 17.5% market share, equivalent to approximately USD 7.98 billion in 2025, and are projected to expand at a CAGR of 5.5%. Their relatively flexible deployment across hospitals, outpatient facilities, community diagnostics, cardiovascular care, women's health, and point-of-care settings supports a broad and recurring equipment market.

Nuclear Imaging Systems accounted for 10.5% of the market, or approximately USD 4.79 billion in 2025, and are expected to grow at a CAGR of 5.0%. PET/CT, SPECT, and related systems remain smaller by procedure volume but carry significant commercial value because of their specialized equipment, radiopharmaceutical, infrastructure, and oncology-related requirements.

Mammography Systems represented 8.5% of the market, valued at approximately USD 3.88 billion in 2025, and are projected to grow at a CAGR of 5.7%. Demand is supported by breast-imaging programs, replacement of conventional systems, digital mammography adoption, tomosynthesis, and continued investment in dedicated women's imaging infrastructure.

 

Impact of Portability on Diagnostic Imaging Equipment Demand

Fixed/Standalone systems dominated the portability segment with a 71.5% share, representing approximately USD 32.60 billion in 2025, and are projected to grow at a CAGR of 4.8%. Their leadership reflects the concentration of CT, MRI, mammography, nuclear imaging, and high-throughput radiography equipment in hospitals and established diagnostic facilities where dedicated rooms and supporting infrastructure are available.

Portable/Mobile systems accounted for 28.5% of the market, valued at approximately USD 13.00 billion in 2025, and are forecast to grow faster at a CAGR of 6.6%. Demand is increasing as hospitals, emergency departments, critical-care units, outpatient facilities, and decentralized care settings use mobile X-ray, portable ultrasound, and other compact imaging technologies to bring diagnostics closer to the patient and reduce dependence on fixed imaging rooms.

 

Clinical Applications Generating the Most Diagnostic Imaging Revenue

Cardiology was the largest application segment with a 20.5% market share, equivalent to approximately USD 9.35 billion in 2025, and is projected to expand at a CAGR of 5.6%. Imaging demand spans ultrasound, CT, MRI, nuclear imaging, and image-guided workflows, creating opportunities across multiple equipment categories rather than a single modality.

Oncology accounted for 18.5% of the market, representing approximately USD 8.44 billion in 2025, and is expected to record the fastest application CAGR of 6.3%. CT, MRI, PET/CT, mammography, and other imaging technologies are used across detection, staging, treatment planning, response assessment, and surveillance, making oncology an important driver of advanced imaging utilization and capital investment.

Neurology represented 15.5% of the market, valued at approximately USD 7.07 billion in 2025, and is projected to grow at a CAGR of 5.9%. MRI and CT remain particularly important for neurological imaging, supporting demand for advanced reconstruction, rapid acquisition, and higher-capability systems.

Orthopedics held a 14.5% market share, equivalent to approximately USD 6.61 billion in 2025, and is expected to expand at a CAGR of 4.9%. X-ray remains central to high-volume musculoskeletal imaging, while MRI, CT, and ultrasound support more detailed evaluation and specialty orthopedic workflows.

Obstetrics and Gynecology accounted for 12.0% of the market, representing approximately USD 5.47 billion in 2025, and are projected to grow at a CAGR of 5.4%. Ultrasound represents a major component of this segment, while MRI and dedicated women's imaging systems provide additional demand in more complex diagnostic pathways.

Gastroenterology represented 10.5% of the market, valued at approximately USD 4.79 billion in 2025, and is forecast to grow at a CAGR of 5.1%. CT, MRI, ultrasound, and nuclear imaging are used across abdominal and gastrointestinal diagnostic pathways, supporting recurring utilization across hospital and outpatient settings.

Other applications accounted for the remaining 8.5% share, equivalent to approximately USD 3.88 billion in 2025, and are projected to expand at a CAGR of 4.5%. This category includes a range of diagnostic uses outside the major application groups and contributes to the broad utilization base of general imaging equipment.

 

End Users Account for the Largest Diagnostic Imaging Market Revenue

Hospitals dominated the end-user segment with a 56.5% market share, representing approximately USD 25.76 billion in 2025, and are projected to grow at a CAGR of 5.1%. Their leadership reflects high procedure volumes and the concentration of CT, MRI, nuclear imaging, X-ray, ultrasound, and specialty imaging infrastructure within acute and tertiary-care facilities.

Diagnostic Imaging Centers accounted for 22.5% of the market, valued at approximately USD 10.26 billion in 2025, and are expected to expand at a CAGR of 5.8%. Their growth is linked to outpatient imaging demand, dedicated scanner utilization, shorter scheduling pathways, and provider efforts to shift appropriate diagnostic activity away from higher-cost hospital environments.

Ambulatory Surgical Centers represented 8.5% of the market, equivalent to approximately USD 3.88 billion in 2025, and are projected to record the fastest end-user CAGR of 6.1%. Increased outpatient procedures and demand for compact, mobile, and workflow-efficient imaging technologies support greater imaging investment in ambulatory environments.

Specialty Clinics held a 7.5% market share, representing approximately USD 3.42 billion in 2025, and are projected to grow at a CAGR of 5.5%. Demand is concentrated around application-specific imaging in areas such as cardiology, orthopedics, women's health, and other specialty practices where dedicated equipment can support faster diagnosis and more integrated clinical workflows.

Other end users accounted for 5.0% of the market, valued at approximately USD 2.28 billion in 2025, and are expected to expand at a CAGR of 4.6%. These settings contribute incremental demand for imaging systems where decentralized or specialized diagnostic capacity is required.

 

How Are Remote Scanning, Automation and Software Changing Imaging Capacity?

Workforce availability is a major constraint on diagnostic imaging capacity, often limiting how fully scanners can be used. Even when hospitals add new equipment, throughput may not rise if there are not enough radiographers, technologists, and radiologists to operate and interpret scans. As a result, focus is shifting toward improving efficiency within existing resources.

Remote scanning is one solution. The American College of Radiology notes that modern CT and MRI systems can support remote operation, helping improve access to expertise and extend service coverage, especially in underserved areas. In practice, NHS London is already using remote scanning to support extended MRI operating hours and increase scanner utilization.

Automation and software are also improving performance. FDA-cleared systems such as Canon’s Vantage Galan 3T MRI with AiCE reconstruction (510(k) K243335) and Philips’ CT Rembra RT and CT Areta RT (510(k) K252992) highlight how AI and reconstruction tools can reduce scan times, improve image quality, and streamline workflows.

Overall, these developments show that growth is increasingly driven not just by new hardware, but by software upgrades, automation, and remote capabilities that help increase capacity and extend the value of existing imaging systems.

 

How Is the Diagnostic Imaging Market Developing Across Major Regions?

North America Supporting Diagnostic Imaging Demand

North America is one of the most developed diagnostic imaging markets, supported by strong hospital networks, high imaging use, and established reimbursement systems, accounting for a 36.5% market share valued at approximately USD 16.64 billion in 2025 and projected to grow at a CAGR of 4.8%. The U.S. has about 86 CT, MRI, and PET scanners per million people, well above the OECD average of 51, driving steady demand for equipment upgrades, replacements, and advanced imaging systems.

Canada has lower capacity at around 26 scanners per million people, leading to longer wait times for MRI and CT scans. Provinces like Saskatchewan are increasing imaging volumes and investing in additional capacity, highlighting ongoing demand for new scanners, efficiency tools, and technologies that improve workflow and patient throughput.

 

Europe Is Expanding Diagnostic Imaging Capacity

Europe held a 27.5% market share, valued at USD 12.54 billion in 2025, and is projected to grow at a CAGR of 4.9%, reflecting a mature imaging market where demand is rising due to efforts to reduce backlogs and expand access. In England alone, around 50.8 million diagnostic imaging tests were performed between April 2025 and March 2026, putting pressure on hospital capacity.

To address this, the NHS is expanding Community Diagnostic Centres. For example, new MRI scanners at Wembley are expected to add over 26,000 scans per year, while Eltham is receiving new ultrasound and DEXA equipment to increase daily patient capacity.

Overall, growth in Europe is driven by equipment replacement, digital workflow upgrades, energy efficiency needs, and the push to improve productivity despite limited specialist staffing.

 

Asia Pacific as a Major Diagnostic Imaging Investment Market

Asia Pacific includes both mature and fast-growing imaging markets, accounting for a 25.5% market share valued at approximately USD 11.63 billion in 2025 and is projected to grow at a CAGR of 6.5%. Japan is one of the most equipment-dense countries globally, with about 184 CT, MRI, and PET scanners per million people (OECD data), meaning demand is driven mainly by equipment replacement, upgrades, and advanced imaging software and services.

In contrast, Indonesia is expanding capacity through large public procurement programs covering hundreds of CT, MRI, mammography, and X-ray systems. GE HealthCare’s agreement to supply over 300 CT scanners highlights the scale of this rollout, which also increases demand for installation, training, maintenance, and long-term service support.

Across the wider region, demographic growth, hospital development, oncology investment, cardiovascular care, emergency services, and efforts to extend advanced diagnostics beyond major metropolitan centres continue to support scanner deployment.

 

Latin America’s Advancement in Diagnostic Imaging Infrastructure

Latin America’s diagnostic imaging market, accounting for a 6.0% share valued at approximately USD 2.74 billion in 2025 and projected to grow at a CAGR of 5.8%, is developing through hospital modernization, private diagnostic networks, replacement of aging equipment, and efforts to improve access to advanced modalities. Major urban healthcare systems typically have greater CT and MRI availability, while uneven infrastructure across secondary cities and rural areas creates room for incremental capacity expansion.

The commercial opportunity is particularly relevant for vendors able to offer scalable equipment configurations, financing support, dependable service networks, and systems suited to high-throughput general imaging. Digital X-ray, ultrasound, CT, and mid-range MRI systems are important because health systems must balance advanced diagnostic capability with capital and operating constraints. Private hospital groups and imaging centres also contribute to demand for premium systems where examination volumes and reimbursement support higher utilization.

 

Middle East and Africa Diagnostic Imaging Market Evolution

The Middle East and Africa market varies widely in healthcare spending and imaging access. The Middle East and Africa market accounted for 4.5% share, valued at USD 2.05 billion in 2025, and is projected to grow at a CAGR of 6.0%. Gulf countries are investing heavily in hospitals and advanced diagnostics, driving demand for CT, MRI, PET/CT, and integrated imaging systems.

In contrast, many African markets are still focused on expanding basic imaging capacity, especially X-ray and ultrasound due to lower cost and easier setup. CT use is growing mainly in major urban and tertiary hospitals. Overall, vendors that offer strong local service, training, financing options, and reliable maintenance are better positioned, as equipment downtime and limited specialist availability remain key challenges.

 

How Is Competition Developing in the Diagnostic Imaging Market?

The Diagnostic Imaging Market is concentrated around large global medical-technology companies with broad portfolios spanning equipment, software, informatics, maintenance, and clinical workflow services. Competition increasingly depends on scanner productivity, image reconstruction, automation, interoperability, regulatory execution, service coverage, and the ability to support multi-site health systems and national procurement programs.

GE HealthCare's Diagnostic Imaging Portfolio

GE HealthCare maintains a broad diagnostic imaging portfolio covering CT, MRI, molecular imaging, X-ray, mammography, image-guided care, and related software and digital technologies. Its Imaging business generated approximately USD 9.20 billion of organic revenue in 2025 compared with USD 8.86 billion in 2024, representing 3.8% organic growth.

The company also competes through large-scale public-health deployments. Its Indonesian program includes the supply of more than 300 advanced CT scanners, alongside prior MRI procurement and investments in local production and imaging training. This combination of equipment, installation, workforce training, and service infrastructure strengthens its position in large national modernization projects as well as mature replacement markets.

 

Siemens Healthineers' Diagnostic Imaging Portfolio

Siemens Healthineers competes across MRI, CT, X-ray, mammography, molecular imaging, ultrasound, image-guided therapy, and imaging software. Its product strategy emphasizes high-end scanner performance alongside automation, digital workflow, reconstruction technologies, and integrated clinical applications.

The company reported 2.3% comparable revenue growth for its Imaging segment in the third quarter of fiscal 2026 and an adjusted EBIT margin of 26.5%. Its equipment book-to-bill ratio reached 1.27 during the quarter, demonstrating continued order activity. Siemens Healthineers' broad installed base also creates recurring opportunities in maintenance, upgrades, software, and lifecycle services.

 

Philips' Diagnostic Imaging Portfolio

Philips participates across CT, MRI, image-guided therapy, diagnostic informatics, ultrasound, and enterprise imaging technologies. Its portfolio is increasingly positioned around integrated workflow, automation, image reconstruction, and software-supported productivity rather than scanner hardware alone.

The FDA's March 2026 clearance of Philips CT Rembra RT and CT Areta RT systems under 510(k) K252992 expanded its U.S. CT offering. Philips also has a significant position in image-guided therapy and informatics, allowing it to compete for broader hospital imaging and clinical workflow contracts rather than isolated scanner purchases.

 

Canon Medical Systems' Diagnostic Imaging Portfolio

Canon Medical Systems competes across CT, MRI, ultrasound, X-ray, interventional imaging, and associated clinical applications. Its portfolio includes high-field MRI systems and advanced reconstruction technologies intended to improve image quality and workflow efficiency.

The FDA cleared Canon's Vantage Galan 3T MRI with an AiCE reconstruction processing unit under 510(k) K243335 in January 2025. Canon's competitive position also depends on lifecycle service and regulatory execution, particularly because sophisticated MRI and CT systems remain operational for long periods and undergo continuing hardware and software support.

 

Fujifilm Healthcare's Diagnostic Imaging Portfolio

Fujifilm Healthcare participates across digital radiography, CT, MRI, ultrasound, mammography, endoscopy-related imaging, and enterprise imaging informatics. Its diagnostic-imaging position benefits from the combination of imaging hardware with PACS, workflow software, and broader healthcare IT capabilities.

The company's portfolio allows it to address both high-end hospital systems and distributed imaging environments, including outpatient, ambulatory, and community-based settings. Digital radiography and ultrasound remain particularly relevant where healthcare providers need relatively flexible deployment, while CT, MRI, and enterprise imaging solutions allow Fujifilm to participate in larger hospital modernization programs.

 

Esaote's Diagnostic Imaging Portfolio

Esaote has a more focused diagnostic imaging portfolio centered on ultrasound and dedicated MRI systems. Its positioning differs from the largest diversified manufacturers because it targets specialized and space-conscious imaging environments where compact systems and application-specific configurations can provide an alternative to conventional full-scale installations.

Its ultrasound presence extends across cardiovascular, musculoskeletal, women's health, and general imaging applications, while dedicated MRI systems are used particularly in musculoskeletal imaging. This specialization provides a competitive position in clinics, specialty centres, and healthcare environments where workflow requirements differ from large tertiary hospitals.

 

What Will Determine the Next Phase of Diagnostic Imaging Market Growth?

The strongest demand in diagnostic imaging is driven by real capacity gaps rather than general healthcare spending growth. England now performs over 50 million imaging tests annually, while Canada continues to report MRI and CT wait-time pressures. At the same time, countries like Indonesia are rapidly expanding capacity through large-scale public scanner procurement programs.

Future investment will depend on how well providers turn equipment purchases into more completed scans. This is influenced by scanner availability, staffing levels, reporting capacity, operating hours, reimbursement, and system uptime. As a result, vendors are increasingly competing on overall workflow efficiency and productivity, not just hardware performance.

CT and MRI remain the main investment focus due to high usage and replacement needs. X-ray and ultrasound continue to see steady demand because of their wide use across healthcare settings. PET/CT and molecular imaging remain smaller but important, especially in oncology, where reimbursement and clinical demand strongly influence adoption.

 

Diagnostic Imaging Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 45.60 Billion
Revenue Forecast in 2032	USD 65.46 Billion
Overall Growth Rate	CAGR of 5.3% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product Type, By Portability, By Application, By End User, By Geography
By Product Type	X-ray Imaging Systems, Computed Tomography Systems, Magnetic Resonance Imaging Systems, Ultrasound Systems, Nuclear Imaging Systems, Mammography Systems
By Portability	Fixed/Standalone Systems, Portable/Mobile Systems
By Application	Cardiology, Oncology, Neurology, Orthopedics, Obstetrics and Gynecology, Gastroenterology, Others
By End User	Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Specialty Clinics, Others
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Indonesia, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Rising diagnostic imaging examination volumes and capacity pressure, increasing adoption of AI-enabled reconstruction and workflow automation, replacement and modernization of aging imaging systems, expansion of public-sector imaging infrastructure and portable diagnostic capacity
Customization Option	Available upon request